Moreover, several additional oncogenic mutations (apart from KIT mutations) have been detected and serve as new diagnostic and prognostic parameters in patients with advanced SM (SM-AHN, ASM or MCL) 291-295. The gene discussed is KIT; the disease is systemic mastocytosis.